These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1316059)

  • 1. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
    Gotfried MH; Ellison WT
    Am J Med; 1992 Apr; 92(4A):108S-113S. PubMed ID: 1316059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
    Kemper P; Köhler D
    Am J Med; 1992 Apr; 92(4A):98S-102S. PubMed ID: 1316079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study.
    Grassi C; Albera C; Pozzi E
    Am J Med; 1992 Apr; 92(4A):103S-107S. PubMed ID: 1316058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
    Chodosh S; Lakshminarayan S; Swarz H; Breisch S
    Antimicrob Agents Chemother; 1998 Jan; 42(1):114-20. PubMed ID: 9449270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA; Henry D; Bensch G; Jubran A; Chodosh S; Harper L; Tipping D; Talbot GH
    Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study.
    Donowitz GR; Brandon ML; Salisbury JP; Harman CP; Tipping DM; Urick AE; Talbot GH
    Clin Ther; 1997; 19(5):936-53. PubMed ID: 9385482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and effectiveness of lomefloxacin in patients with acute exacerbation of chronic bronchitis (AECB) chronically treated with oral theophyllines.
    Melani AS; Pirrelli M; Sarlo F; Cantoni V;
    J Chemother; 2001 Dec; 13(6):628-34. PubMed ID: 11806624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The U.S. clinical experience with lomefloxacin, a new once-daily fluoroquinolone.
    Rizk E
    Am J Med; 1992 Apr; 92(4A):130S-135S. PubMed ID: 1316063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.
    Klietmann W; Cesana M; Rondel RK; Focht J
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2298-306. PubMed ID: 8285609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections.
    Cox CE
    Am J Med; 1992 Apr; 92(4A):82S-86S. PubMed ID: 1316077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: results of multinational studies.
    Yernault JC; Russell D
    Int J Antimicrob Agents; 1992 Dec; 2(1):39-47. PubMed ID: 18611518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A; Longest KA; Senetar JE; Dere WH
    Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE; Cranfield R; Breisch S; Pettit R
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefaclor in the treatment of infective exacerbations of chronic bronchitis in cigarette smokers.
    Cazzola M; Franco C; Gioia V; Legnani D; Mancini V; Polverino M; Sevieri G
    J Chemother; 1991 Aug; 3(4):245-9. PubMed ID: 1779259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults.
    Iravani A
    Am J Med; 1992 Apr; 92(4A):75S-81S. PubMed ID: 1316075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of lomefloxacin in treatment of patients with chronic bronchitis].
    Fedoseev GB; Emel'ianov AV; Rudinskiĭ KA; Shevelev SE; Bykova AV
    Antibiot Khimioter; 1998; 43(10):24-6. PubMed ID: 9825106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE; Zuck P; Vogel F; McIvor A; Peirzchala W; Smakal M; Staley H; Marr C
    J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
    Chodosh S
    Am J Med; 1991 Dec; 91(6A):93S-100S. PubMed ID: 1662900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.